SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma, Inc. (SGP) is a healthcare company (biotechnology) based in the United States. The share price is $31.03, down 3.77% on the day, which values the company at $1.04B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$31.03−3.77% today
Market value
$1.04B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

SpyGlass Pharma, Inc. in more detail

SGP trades at -10.2× next year's expected earnings.

In its favour: More cash than debt.

1 of the superinvestors tracked here hold SGP, including Peter Kolchinsky (1.6% of the portfolio).

Superinvestors holding SGP

1 of the investors tracked here report a position in their latest 13F filing.

SpyGlass Pharma, Inc. (SGP): questions and answers

What is SpyGlass Pharma, Inc.'s market cap?

SpyGlass Pharma, Inc. is valued at $1.04B at a share price of $31.03.

Does SGP pay a dividend?

SpyGlass Pharma, Inc. does not currently pay a regular dividend.

Which famous investors own SGP?

In their latest quarterly filings, Peter Kolchinsky (1.6% of the portfolio) hold SGP. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “SpyGlass Pharma, Inc. (SGP) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SGP

Underlying data: Yahoo Finance; company filings with the SEC.